摘要:
The technology relates in part to quantification of a minority nucleic acid species from a nucleic acid sample. In some embodiments, kits for determining the amount of fetal nucleic acid (e.g. absolute amount, relative amount) in a maternal sample are provided. The methods employ sequences which are present in fetal, but not in maternal nucleic acids, e.g. methylated sequences in TBX3, SOX14, POP5 and APOE and sequences which are present in Y chromosomes. The kit may also contain inhibitory nucleic acids for reducing the efficiency of the amplification of the dominant nucleic acid and/or target competitors for improving the quantification.
摘要:
Novel Y-STR multiplex analysis designs, primer design, allelic ladders, methods of use and kits are disclosed, including the use of primer sets designed to provide amplicons for at least 11 Y-STR loci having a base pair size of less than about 220 bp, as well as the use of primer sets designed to provide amplicons for at least 22 Y-STR loci including at least 5 rapidly mutating loci.
摘要:
The technology relates in part to quantification of a minority nucleic acid species from a nucleic acid sample. In some embodiments, methods for determining the amount of fetal nucleic acid (e.g. absolute amount, relative amount) in a maternal sample are provided.
摘要:
The present invention relates to a method for determining the presence of a biological condition associated with a nucleic acid species N1 in a test biological sample obtained from a patient, said biological sample comprising two nucleic acid species N1 and N2, wherein the method comprises: a) determining the total amount [N1 + N2] and comparing said total amount to at least one discrimination threshold T; b) determining the relative amount N1:N2 and comparing said relative amount to at least one discrimination threshold R specific for the method of step (a); and c) on the basis of the comparisons carried out in step (a) and (b), determining the presence of the biological condition. The method generally comprises extraction of the total nucleic acids from a sample; optionally enrichment of the species N1,possibly by size selection; attribution of sequenced nucleic acids larger than 50 bp to individual chromosomes; and comparison of sequence reads with references.
摘要:
The invention relates to a detection method performed on a maternal serum or plasma sample from a pregnant female, which method comprises detecting the presence of a nucleic acid of foetal origin in the sample. The invention enables non-invasive prenatal diagnosis including for example sex determination, blood typing and other genotyping, and detection of pre-eclampsia in the mother.